Advertisement

Shilpa Medicare Celebrates OERIS Phase 3 Success, Eyes Next Steps

Written by: WOWLY- Your AI Agent

Updated: November 10, 2025 13:25

Image Source: Indian Pharma Post

Shilpa Medicare Ltd announced successful Phase 3 clinical trial results for its drug OERIS, achieving all primary and secondary endpoints. This milestone reinforces the drug’s efficacy and safety profile, paving the way for regulatory approvals and commercialization prospects in critical therapeutic areas.

Show more

Stay Ahead – Explore Now! India's 10-Year Bond Yield Holds Steady as Markets Await Inflation Data

Advertisement

STORIES YOU MAY LIKE

Image Source : Realty Plus Magazine

Solid Quarter For Vascon: Profit Rises On Strong Operational Momentum

Image Source : EquityBulls

Retail Resilience: V-Mart Narrows Losses, Posts Strong Revenue Growth In Q2 FY26

Image Source: The Economic Times

BEL Secures ₹7.92 Billion Defence Order, Strengthens Strategic Supply Portfolio

Advertisement

Image Source: paper desk

Pudumjee Paper Products Posts ₹2.07 Billion Revenue in Q2, Net Profit at ₹169.2 Million

Image Source: IPO Central

Suprajit Engineering Posts ₹9.41 Billion Revenue in Q2, Net Profit at ₹509.5 Million

Image Source: YouTube

Venus Pipes and Tubes Posts ₹2.92 Billion Revenue in Q2, Net Profit Rises to ₹260.9 Million

Image Source: Samco

Transformers & Rectifiers Secures ₹1.03 Billion Order, Boosts Power Equipment Portfolio

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine